NCT00494143

Brief Summary

To determine if below-knee amputees will walk with better efficiency wearing a CESR foot which stores energy at heel strike and releases energy releases energy during push-off.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jul 2007

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 29, 2007

Completed
2 days until next milestone

Study Start

First participant enrolled

July 1, 2007

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
3.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

June 9, 2014

Completed
Last Updated

June 9, 2014

Status Verified

May 1, 2014

Enrollment Period

1.8 years

First QC Date

June 28, 2007

Results QC Date

August 30, 2013

Last Update Submit

May 21, 2014

Conditions

Keywords

AmputeeEconomyEfficiencyFootGaitKinematicsKineticsProsthesis

Outcome Measures

Primary Outcomes (1)

  • Metabolic Oxygen Consumption During Ambulation

    VO2 was collected at rest and while walking at a controlled walking speed of 1.14 meters/second for 10 minutes until they reached a steady state for 3 minutes. This was repeated for each foot condition. VO2 at the steady state was recorded in ml/min and were subsequently converted to calories and and then to Watts. The data were then corrected for body weight by dividing by weight in Kg. The gross VO2 in Watts/Kg during walking were then adjusted to net VO2 in Watts/kg by subtracting the resting metabolic rate.

    Subjects were oriented to the testing protocol and each prosthetic foot on average 5 days prior to data collection and a acclimatization period of 5-10 minutes with each prosthetic foot prior to data collection

Secondary Outcomes (2)

  • Prosthetic Foot Push Off Peak Power

    Subjects were oriented to the testing protocol and each prosthetic foot on average 5 days prior to data collection and a acclimatization period of 5-10 minutes with each prosthetic foot prior to data collection

  • Peak Intact Knee Loading

    Subjects were oriented to the testing protocol and each prosthetic foot on average 5 days prior to data collection and a acclimatization period of 5-10 minutes with each prosthetic foot prior to data collection

Study Arms (3)

Conventional Prosthetic foot

ACTIVE COMPARATOR

A conventional prosthetic foot that has limited energy storage and return capabilities. It is standardized and used by all subjects in the study.

Device: typical prosthetic foot

Prescribed Prosthetic foot

ACTIVE COMPARATOR

the Prosthetic foot that the subject had prescribed for them by their clinical providers and was worn prior to study initiation

Device: standardized prosthetic foot

CESR foot

EXPERIMENTAL

the experimental CESR, controlled energy storage prosthetic foot

Device: CESR Prosthetic Foot

Interventions

a novel prosthetic foot that is designed to store energy and release it at a predetermined time in the gait cycle

CESR foot

patients will wear the prosthetic foot that they were prescribed by the care providers in the clinical team

Conventional Prosthetic foot

a standard foot that has had weights applied to match the mass of the CESR foot

Prescribed Prosthetic foot

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Transtibial Amputees \> 1 year walking with prosthesis
  • Non-amputee control subjects

You may not qualify if:

  • Additional musculoskeletal pathology
  • Cognitive limitation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Puget Sound Health Care System, Seattle

Seattle, Washington, 98108, United States

Location

Related Publications (3)

  • Segal AD, Zelik KE, Klute GK, Morgenroth DC, Hahn ME, Orendurff MS, Adamczyk PG, Collins SH, Kuo AD, Czerniecki JM. The effects of a controlled energy storage and return prototype prosthetic foot on transtibial amputee ambulation. Hum Mov Sci. 2012 Aug;31(4):918-31. doi: 10.1016/j.humov.2011.08.005. Epub 2011 Nov 17.

  • Morgenroth DC, Segal AD, Zelik KE, Czerniecki JM, Klute GK, Adamczyk PG, Orendurff MS, Hahn ME, Collins SH, Kuo AD. The effect of prosthetic foot push-off on mechanical loading associated with knee osteoarthritis in lower extremity amputees. Gait Posture. 2011 Oct;34(4):502-7. doi: 10.1016/j.gaitpost.2011.07.001. Epub 2011 Jul 30.

  • Zelik KE, Collins SH, Adamczyk PG, Segal AD, Klute GK, Morgenroth DC, Hahn ME, Orendurff MS, Czerniecki JM, Kuo AD. Systematic variation of prosthetic foot spring affects center-of-mass mechanics and metabolic cost during walking. IEEE Trans Neural Syst Rehabil Eng. 2011 Aug;19(4):411-9. doi: 10.1109/TNSRE.2011.2159018. Epub 2011 Jun 23.

Limitations and Caveats

Acclimatization to a prosthetic foot type can alter the measured performance. In this study, subjects were most experienced using their prescribed foot. The CESR foot was also only available in one foot size which can affect gait characteristics.

Results Point of Contact

Title
Dr. Joseph Czerniecki
Organization
VA Puget Sound Health Care System

Study Officials

  • Joseph M. Czernieki, MD MS

    VA Puget Sound Health Care System, Seattle

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2007

First Posted

June 29, 2007

Study Start

July 1, 2007

Primary Completion

May 1, 2009

Study Completion

December 1, 2012

Last Updated

June 9, 2014

Results First Posted

June 9, 2014

Record last verified: 2014-05

Locations